Post by Advanced Chemistry Development, Inc., (ACD/Labs)

AstraZeneca's path to automated NMR analysis didn't happen overnight. It started with a commitment to digitalizing NMR data, and over the past two decades, that foundation has helped drive progress toward increasingly automated workflows. See how their journey is bringing them closer to autonomous structure verification in our latest case study: http://ms.spr.ly/6040vUTYO